Clinical Trials
5 trialsNCT03357471 2019-10-25
Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease
UCB Pharma
Phase 3 Completed
NCT00552058 2018-08-09
Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
UCB Pharma
Phase 3 Completed
NCT00333788 2018-08-07
Welcome2
UCB Pharma
Phase 3 Completed
NCT01374971 2014-04-08
Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)
Arthritis Treatment Center, Maryland
Phase 3 Completed
NCT00297648 2011-08-31
MUSIC
UCB Pharma
Phase 3 Completed